Intercept Pharmaceuticals, Inc.

ICPTDelisted Nov 8, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001270073

SEC filings (opens in a new tab)

Intercept Pharmaceuticals, Inc. was delisted on Nov 8, 2023; its insiders filed their last Form 4 on Nov 13, 2023; 146 institutions reported holding it in 13F filings for Q3 2023, worth $724.6M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Intercept Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of ICPT: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Of which not filed for Q3 2022	Q3 2022	Change
Holders	145	1	156	+12
Shares	24.3M	6	28.9M	+4.58M (+18.8%)
Value	$336.1M	$83	$402.4M	+$66.3M (+19.7%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (31)

Institutions that held Intercept Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ICPT in Q3 2022
Institution	Shares	Value	% of portfolio
Jane Street Group, LLC	290,537	$4.05M	0.01%
Graham Capital Management, L.P.	120,367	$1.68M	0.07%
Great Point Partners LLC	105,000	$1.47M	0.35%
Ally Bridge Group (NY) LLC	100,000	$1.40M	0.92%
Susquehanna Fundamental Investments, LLC	91,832	$1.28M	0.02%
Caption Management, LLC	86,859	$1.21M	0.21%
Group One Trading, L.P.	84,141	$1.17M	0.04%
ExodusPoint Capital Management, LP	83,939	$1.17M	0.02%
Virginia Retirement Systems Et Al	56,500	$788.2K	0.01%
Schonfeld Strategic Advisors LLC	50,503	$705.0K	0.01%
Engineers Gate Manager LP	50,390	$703.0K	0.04%
Adage Capital Partners GP, L.L.C.	50,000	$698.0K	0.00%
Campbell & CO Investment Adviser LLC	49,122	$685.0K	0.16%
D. E. Shaw & Co., Inc.	29,342	$409.0K	0.00%
Wolverine Asset Management LLC	25,990	$362.0K	0.01%
Parallax Volatility Advisers, L.P.	21,790	$304.0K	0.01%
Virtu Financial LLC	19,656	$274.0K	0.03%
Skaana Management L.P.	12,954	$181.0K	0.06%
Mirae Asset Global Investments Co., Ltd.	11,605	$162.0K	0.00%
Virtus Investment Advisers, Inc.	8,362	$117.0K	0.05%
Point72 Hong Kong Ltd	4,215	$59.0K	0.00%
US Bancorp	989	$14.0K	0.00%
Cowen and Company, LLC	57,300	$13.0K	0.00%
China Universal Asset Management Co., Ltd.	279	$4.00K	0.00%
Allworth Financial LP	153	$2.00K	0.00%
Federated Hermes, Inc.	70	$1.00K	0.00%
Quadrant Capital Group LLC	64	$1.00K	0.00%
AdvisorNet Financial, Inc	23	$0	0.00%
Signaturefd, LLC	14	$0	0.00%
Lindbrook Capital, LLC	15	$0	0.00%
Delos Wealth Advisors, LLC	16	$0	0.00%

Sold out (19)

Institutions that held Intercept Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ICPT in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Fuller & Thaler Asset Management, Inc.	165,310	$2.28M
Monaco Asset Management SAM	30,000	$414.0K
Bank of Montreal	23,135	$315.0K
Walleye Capital LLC	22,600	$312.0K
Man Group plc	–	$267.0K
Jump Financial, LLC	18,700	$258.0K
Qube Research & Technologies Ltd	16,174	$223.0K
Belvedere Trading LLC	14,967	$216.0K
Stifel Financial Corp	14,691	$203.0K
DuPont Capital Management Corp	11,469	$158.0K
Fox Run Management, L.L.C.	11,216	$155.0K
XTX Topco Ltd	10,784	$149.0K
PEAK6 Investments LLC	3,644	$40.3K
State of Wyoming	2,443	$34.0K
TD Waterhouse Canada Inc.	10	$141
Hudock, Inc.	50	$0
Dark Forest Capital Management LP	19	$0
CoreCap Advisors, LLC	5	$0
International Biotechnology Trust PLC	441	–

Not filed for Q3 2022 yet (1)

Institutions that held Intercept Pharmaceuticals, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ICPT in Q2 2022 that haven't filed for Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Exane Derivatives	6	$83